Full Press Release Details
MINNEAPOLIS, April 17, 2018 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (the "Company") (TSX-V:DMA) (OTCQB:DMCAF), today announced the issuance of 2,551,000 stock options to various officers and directors of the Company. The options were issued at $0.56 per share and have a ten-year term.
The options were granted under the Company's Stock Option Plan and are part of the Company's long term incentive/retention plan for employees. The option issuance is subject to the approval of the TSX Venture Exchange.
About DiaMedica Therapeutics Inc.
Vice President of Business Development
DiaMedica Therapeutics Inc.
Phone: (617) 899-5941
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the contents of this press release.